110 related articles for article (PubMed ID: 31013810)
1. Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR
Guo Z; Tada H; Kitamura N; Hamada Y; Miyashita M; Harada-Shoji N; Sato A; Hamanaka Y; Tsuboi K; Harada N; Takano-Kasuya M; Okada H; Nakano Y; Ohuchi N; Hayashi SI; Ishida T; Gonda K
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013810
[TBL] [Abstract][Full Text] [Related]
2. Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness.
Gonda K; Watanabe M; Tada H; Miyashita M; Takahashi-Aoyama Y; Kamei T; Ishida T; Usami S; Hirakawa H; Kakugawa Y; Hamanaka Y; Yoshida R; Furuta A; Okada H; Goda H; Negishi H; Takanashi K; Takahashi M; Ozaki Y; Yoshihara Y; Nakano Y; Ohuchi N
Sci Rep; 2017 Aug; 7(1):7509. PubMed ID: 28790306
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
Iwase H; Zhang Z; Omoto Y; Sugiura H; Yamashita H; Toyama T; Iwata H; Kobayashi S
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S34-8. PubMed ID: 12819932
[TBL] [Abstract][Full Text] [Related]
5. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
Kulkoyluoglu E; Madak-Erdogan Z
Steroids; 2016 Oct; 114():41-47. PubMed ID: 27394959
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.
Thaler S; Schmidt M; Roβwag S; Thiede G; Schad A; Sleeman JP
Oncotarget; 2017 Sep; 8(42):72281-72301. PubMed ID: 29069787
[TBL] [Abstract][Full Text] [Related]
7. A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.
Skliris GP; Nugent ZJ; Rowan BG; Penner CR; Watson PH; Murphy LC
Endocr Relat Cancer; 2010 Sep; 17(3):589-97. PubMed ID: 20418363
[TBL] [Abstract][Full Text] [Related]
8. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
9. A New Role for Estrogen Receptor α in Cell Proliferation and Cancer: Activating the Anticipatory Unfolded Protein Response.
Livezey M; Kim JE; Shapiro DJ
Front Endocrinol (Lausanne); 2018; 9():325. PubMed ID: 29963013
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
11. Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor.
Shinoda H; Legare ME; Mason GL; Berkbigler JL; Afzali MF; Flint AF; Hanneman WH
J Vet Diagn Invest; 2014 May; 26(3):390-403. PubMed ID: 24760135
[TBL] [Abstract][Full Text] [Related]
12. A functional drug re-purposing screening identifies carfilzomib as a drug preventing 17β-estradiol: ERα signaling and cell proliferation in breast cancer cells.
Busonero C; Leone S; Klemm C; Acconcia F
Mol Cell Endocrinol; 2018 Jan; 460():229-237. PubMed ID: 28760601
[TBL] [Abstract][Full Text] [Related]
13. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
14. Interplay between steroid hormone activation of the unfolded protein response and nuclear receptor action.
Zheng X; Andruska N; Yu L; Mao C; Kim JE; Livezey M; Helferich WG; Shapiro DJ
Steroids; 2016 Oct; 114():2-6. PubMed ID: 27016130
[TBL] [Abstract][Full Text] [Related]
15. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis.
Li C; Fan H; Xiang Q; Xu L; Zhang Z; Liu Q; Zhang T; Ling J; Zhou Y; Zhao X; Cui Y
Breast Cancer Res Treat; 2019 Dec; 178(3):497-504. PubMed ID: 31471838
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.
Nishimoto M; Nishikawa S; Kondo N; Wanifuchi-Endo Y; Hato Y; Hisada T; Dong Y; Okuda K; Sugiura H; Kato H; Takahashi S; Toyama T
Jpn J Clin Oncol; 2019 Jun; 49(6):567-575. PubMed ID: 30855679
[TBL] [Abstract][Full Text] [Related]
18. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
Motomura K; Ishitobi M; Komoike Y; Koyama H; Nagase H; Inaji H; Noguchi S
Oncology; 2010; 79(1-2):55-61. PubMed ID: 21071990
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
